Description of the project

Despite the existence of ACTs that cure malaria in just three days, nearly one million people continue to die annually, because of insufficient access to this effective treatment. The high cost of ACTs is a critical barrier, as is the low availability of paediatric ACT formulations. Without the prospect of sustainable funding that enables effective planning, countries remain reluctant to switch from the far-cheaper and less effective chloroquine to ACTs.

UNITAID and its partners are helping increase access to ACTs by providing a sustainable financing model. UNITAID is promoting greater competition in the ACT market, thereby fostering lower prices, by sending a signal of its long-term commitment and sustainable funding for ACTs. UNITAIDs target is to treat 43.3 million cases of malaria by 2010-2011.

A.	Project title:	ACT Scale-up
B.	Timeframe:	Project duration: 2007 - 2011
C.	Amount committed by UNITAID:	US $ 65 413 057
D.	Lead partner:	the Global Fund to Fight AIDS, Tuberculosis and Malaria and UNICEF
E.	Other: